Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Intel shares pop on report US govt mulling investment

(Sharecast News) - Intel shares jumped in pre-market trade after a report that the US government is mulling taking a stake in the chipmaker. The talks follow a meeting this week between President Donald Trump and Intel boss Lip-Bu Tan, just days after the authoritarian leader called for Tan's removal over his ties to China.

The deal would help shore up Intel's planned factory hub in Ohio, Bloomberg reported, citing unnamed sources. Intel last month warned it may exit chip manufacturing without external customers and plans to slow construction on its Ohio factories.

Hargreaves Lansdown analyst Matt Britzman said the strategic rationale "makes sense from President Trump's standpoint, as securing domestic chipmaking capacity is a key priority".

"For Intel, what a difference a week makes, as Trump pivots from calling for CEO Lip-Bu's resignation due to alleged China conflicts to a much friendlier stance. Clearly, the meeting between the two went well, and direct government support could provide a much-needed boost to support Intel's struggling onshore foundry business."

Earlier this week, the government unveiled a deal where it would take 15% of revenues from chipmakers Nvidia and Advanced Micro Devices from their chip sales to China. Last month, the defence department also announced it would take a $400m preferred stake in the US rare earth producer MP Materials.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.